Condition

Neuroendocrine Neoplasm of Lung

ClinicalTrials.gov condition label

Clinical trials4

Recruiting2

Common interventions3

Lead sponsors shown4

Clinical trials

4 shown

Risk Factors for Neuroendocrine NeoplasmsNCT06282016 · 2025-05-15

RECRUITING

Genetic Bases of Neuroendocrine Neoplasms in Mexican PatientsNCT06523582 · 2022-08-03

RECRUITING

Everolimus TDM to Predict Long Term ToxicityNCT03033186 · 2017-05-16

UNKNOWN

Durvalumab (MEDI4736) Plus Tremelimumab for Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic or Lung OriginNCT03095274 · 2017-04-11

COMPLETED

Common interventions

Case-control study (no intervention)OTHER1DurvalumabDRUG1TremelimumabDRUG1

Leading sponsors

Bavarian Cancer Registry1Grupo Espanol de Tumores Neuroendocrinos1Maastricht University Medical Center1Universidad Nacional Autonoma de Mexico1

Trial status mix

RECRUITING2

COMPLETED1

UNKNOWN1

Phase mix

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.